Retraction statement: Safety and efficacy of tramadol in the treatment of idiopathic detrusor overactivity: A double-blind, placebo-controlled, randomized study

doi:10.1111/bcp.12304

Retraction statement: Safety and efficacy of tramadol in the treatment of idiopathic detrusor overactivity: A double-blind, placebo-controlled, randomized study

British Journal of Clinical Pharmacology ◽

10.1111/bcp.12304 ◽

2013 ◽

Vol 77 (1) ◽

pp. 216-216

Keyword(s):

Detrusor Overactivity ◽

Randomized Study ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Idiopathic Detrusor Overactivity

Download Full-text

Retracted:Safety and efficacy of tramadol in the treatment of idiopathic detrusor overactivity: a double-blind, placebo-controlled, randomized study

British Journal of Clinical Pharmacology ◽

10.1111/j.1365-2125.2006.02597.x ◽

2006 ◽

Vol 61 (4) ◽

pp. 456-463 ◽

Cited By ~ 34

Author(s):

M. R. Safarinejad ◽

S. Y. Hosseini

Keyword(s):

Detrusor Overactivity ◽

Randomized Study ◽

Double Blind ◽

Double Blind Placebo ◽

Idiopathic Detrusor Overactivity

Download Full-text

Safety and efficacy of citalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study

International Journal of Impotence Research ◽

10.1038/sj.ijir.3901384 ◽

2005 ◽

Vol 18 (2) ◽

pp. 164-169 ◽

Cited By ~ 33

Author(s):

M R Safarinejad ◽

S Y Hosseini

Keyword(s):

Premature Ejaculation ◽

Randomized Study ◽

Fixed Dose ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

BOTULINUM TOXIN A IS SAFE AND EFFECTIVE IN THE TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER AND IDIOPATHIC DETRUSOR OVERACTIVITY: RESULTS FROM A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

European Urology Supplements ◽

10.1016/s1569-9056(06)60387-4 ◽

2006 ◽

Vol 5 (2) ◽

pp. 118 ◽

Cited By ~ 3

Author(s):

A. Sahai ◽

S. Khan ◽

P. Dasgupta

Keyword(s):

Botulinum Toxin ◽

Overactive Bladder ◽

Detrusor Overactivity ◽

Botulinum Toxin A ◽

Controlled Trial ◽

Toxin A ◽

Double Blind ◽

Double Blind Placebo ◽

Idiopathic Detrusor Overactivity

Download Full-text

Safety and Efficacy of Dapoxetine in the Treatment of Premature Ejaculation: A Double-Blind, Placebo-Controlled, Fixed-Dose, Randomized Study

Neuropsychopharmacology ◽

10.1038/sj.npp.1301500 ◽

2007 ◽

Vol 33 (6) ◽

pp. 1259-1265 ◽

Cited By ~ 24

Author(s):

Mohammad R Safarinejad

Keyword(s):

Premature Ejaculation ◽

Randomized Study ◽

Fixed Dose ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial

BJU International ◽

10.1111/j.1464-410x.2009.08402.x ◽

2009 ◽

Vol 103 (11) ◽

pp. 1509-1515 ◽

Cited By ~ 47

Author(s):

Arun Sahai ◽

Christopher Dowson ◽

Mohammad S. Khan ◽

Prokar Dasgupta

Keyword(s):

Quality Of Life ◽

Botulinum Toxin ◽

Detrusor Overactivity ◽

Botulinum Toxin A ◽

Controlled Trial ◽

Toxin A ◽

Double Blind ◽

Double Blind Placebo ◽

Idiopathic Detrusor Overactivity

Download Full-text

Re: Efficacy of Botulinum Toxin-A for Treating Idiopathic Detrusor Overactivity: Results from a Single Center, Randomized, Double-Blind, Placebo Controlled Trial

European Urology ◽

10.1016/j.eururo.2007.09.024 ◽

2007 ◽

Vol 52 (6) ◽

pp. 1793-1794 ◽

Cited By ~ 1

Author(s):

Thomas M. Kessler

Keyword(s):

Botulinum Toxin ◽

Detrusor Overactivity ◽

Botulinum Toxin A ◽

Controlled Trial ◽

Single Center ◽

Toxin A ◽

Double Blind ◽

Double Blind Placebo ◽

Idiopathic Detrusor Overactivity

Download Full-text

RETRACTED: Evaluation of the Safety and Efficacy of Bremelanotide, a Melanocortin Receptor Agonist, in Female Subjects with Arousal Disorder: A Double-Blind Placebo-Controlled, Fixed Dose, Randomized Study

Journal of Sexual Medicine ◽

10.1111/j.1743-6109.2007.00698.x ◽

2008 ◽

Vol 5 (4) ◽

pp. 887-897 ◽

Cited By ~ 52

Author(s):

Mohammad Reza Safarinejad

Keyword(s):

Receptor Agonist ◽

Randomized Study ◽

Melanocortin Receptor ◽

Fixed Dose ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Arousal Disorder ◽

Female Subjects

Download Full-text

Retraction Note: Safety and efficacy of sildenafil citrate in the treatment of Parkinson-emergent erectile dysfunction: a double-blind, Placebo-controlled, randomized study

International Journal of Impotence Research ◽

10.1038/ijir.2011.11 ◽

2011 ◽

Vol 23 (2) ◽

pp. 94-94

Author(s):

M R Safarinejad ◽

A Taghva ◽

B Shekarchi ◽

Sh Safarinejad

Keyword(s):

Erectile Dysfunction ◽

Randomized Study ◽

Sildenafil Citrate ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Evaluation of the Safety and Efficacy of Sildenafil Citrate for Erectile Dysfunction in Men With Multiple Sclerosis: A Double-Blind, Placebo Controlled, Randomized Study

The Journal of Urology ◽

10.1016/j.juro.2008.09.003 ◽

2009 ◽

Vol 181 (1) ◽

pp. 252-258 ◽

Cited By ~ 42

Author(s):

Mohammad Reza Safarinejad

Keyword(s):

Multiple Sclerosis ◽

Erectile Dysfunction ◽

Randomized Study ◽

Sildenafil Citrate ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text

Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study

International Journal of Impotence Research ◽

10.1038/ijir.2010.20 ◽

2010 ◽

Vol 22 (5) ◽

pp. 298-309 ◽

Cited By ~ 26

Author(s):

M R Safarinejad

Keyword(s):

Coenzyme Q10 ◽

Randomized Study ◽

Peyronie’S Disease ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Peyronie's Disease ◽

Coenzyme Q10 Supplementation

Download Full-text